Transcription factor Zbtb38 downregulates the expression of anti-inflammatory IL1r2 in mouse model of rheumatoid arthritis.

[1]  H. Heng,et al.  Transient and stable vector transfection: Pitfalls, off-target effects, artifacts. , 2017, Mutation research.

[2]  L. Poellinger,et al.  A Molecular Mechanism To Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase , 2017, Molecular and Cellular Biology.

[3]  Tommy W. Terooatea,et al.  Cell-specific Kaiso (ZBTB33) Regulation of Cell Cycle through Cyclin D1 and Cyclin E1* , 2016, The Journal of Biological Chemistry.

[4]  Richard D Emes,et al.  Genome-wide profiling in treatment-naive early rheumatoid arthritis reveals DNA methylome changes in T and B lymphocytes. , 2016, Epigenomics.

[5]  K. Deane.  Rheumatoid arthritis: Autoantibodies, citrullinated histones and initiation of synovitis , 2015, Nature Reviews Rheumatology.

[6]  C. Gabay,et al.  The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases. , 2015, Cytokine.

[7]  Seong‐Su Han,et al.  SUMOylation-disrupting WAS mutation converts WASp from a transcriptional activator to a repressor of NF-κB response genes in T cells. , 2015, Blood.

[8]  O. Elemento,et al.  DNA Methylation Dynamics of Germinal Center B Cells Are Mediated by AID. , 2015, Cell reports.

[9]  Ronald P. Schuyler,et al.  Whole-genome fingerprint of the DNA methylome during human B cell differentiation , 2015, Nature Genetics.

[10]  Y. Iwakura,et al.  IL-1 Receptor Type 2 Suppresses Collagen-Induced Arthritis by Inhibiting IL-1 Signal on Macrophages , 2015, The Journal of Immunology.

[11]  G. Dressler,et al.  The Groucho-associated Phosphatase PPM1B Displaces Pax Transactivation Domain Interacting Protein (PTIP) to Switch the Transcription Factor Pax2 from a Transcriptional Activator to a Repressor* , 2015, The Journal of Biological Chemistry.

[12]  K. Bock.  Homeostatic control of xeno- and endobiotics in the drug-metabolizing enzyme system. , 2014, Biochemical pharmacology.

[13]  B. Stockinger,et al.  The aryl hydrocarbon receptor: multitasking in the immune system. , 2014, Annual review of immunology.

[14]  C. Garlanda,et al.  Negative regulatory receptors of the IL-1 family. , 2013, Seminars in immunology.

[15]  Kyster K. Nanan,et al.  The POZ-ZF Transcription Factor Kaiso (ZBTB33) Induces Inflammation and Progenitor Cell Differentiation in the Murine Intestine , 2013, PloS one.

[16]  Gyula Hoffmann,et al.  Differentially expressed epigenome modifiers, including aurora kinases A and B, in immune cells in rheumatoid arthritis in humans and mouse models. , 2013, Arthritis and rheumatism.

[17]  P. Farnham,et al.  ZBTB33 binds unmethylated regions of the genome associated with actively expressed genes , 2013, Epigenetics & Chromatin.

[18]  E. Park,et al.  Interferon Gamma Suppresses Collagen-Induced Arthritis by Regulation of Th17 through the Induction of Indoleamine-2,3-Deoxygenase , 2013, PloS one.

[19]  T. Tedder,et al.  IL-10-producing regulatory B cells (B10 cells) in autoimmune disease , 2013, Arthritis Research & Therapy.

[20]  G. Firestein,et al.  Regulation of DNA Methylation in Rheumatoid Arthritis Synoviocytes , 2013, The Journal of Immunology.

[21]  Wei Wang,et al.  DNA methylome signature in rheumatoid arthritis , 2012, Annals of the rheumatic diseases.

[22]  Sung-Uk Lee,et al.  POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function , 2012, Immunological reviews.

[23]  Georg Schett,et al.  The pathogenesis of rheumatoid arthritis. , 2011, The New England journal of medicine.

[24]  Chuan He,et al.  Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine , 2011, Science.

[25]  T. Glant,et al.  Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis. , 2011, Arthritis and rheumatism.

[26]  T. Rauch,et al.  DNA methylation profiling using the methylated-CpG island recovery assay (MIRA). , 2010, Methods.

[27]  J. O'dell,et al.  State-of-the-art: rheumatoid arthritis , 2010, Annals of the rheumatic diseases.

[28]  Xi Liu,et al.  Structural insights into the assembly and activation of IL-1β with its receptors , 2010, Nature Immunology.

[29]  P. Defossez,et al.  Sequence-specific recognition of methylated DNA by human zinc-finger proteins , 2010, Nucleic acids research.

[30]  C. Gabay,et al.  IL-1 pathways in inflammation and human diseases , 2010, Nature Reviews Rheumatology.

[31]  Guillaume J. Filion,et al.  A Family of Human Zinc Finger Proteins That Bind Methylated DNA and Repress Transcription , 2006, Molecular and Cellular Biology.

[32]  Robert Brown,et al.  DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. , 2005, Journal of the National Cancer Institute.

[33]  T. Rauch,et al.  Methylated-CpG island recovery assay: a new technique for the rapid detection of methylated-CpG islands in cancer , 2005, Laboratory Investigation.

[34]  H. Joller-jemelka,et al.  Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. , 2002, The Journal of clinical investigation.

[35]  A. Garcia-Gonzalez,et al.  Interleukin 1beta (IL-1beta), IL-10, tumor necrosis factor-alpha, and cellular proliferation index in peripheral blood mononuclear cells in patients with ankylosing spondylitis. , 2002, The Journal of rheumatology.

[36]  V. Bardwell,et al.  The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT , 1998, Oncogene.

[37]  M. Privalsky,et al.  Components of the SMRT Corepressor Complex Exhibit Distinctive Interactions with the POZ Domain Oncoproteins PLZF, PLZF-RARα, and BCL-6* , 1998, The Journal of Biological Chemistry.

[38]  T. Glant,et al.  Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage. , 1998, Arthritis and rheumatism.

[39]  P. Young,et al.  Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Dayer,et al.  Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis , 1995 .

[41]  S. Dower,et al.  Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. , 1994, Journal of immunology.

[42]  G. Privé,et al.  The BTB domain, found primarily in zinc finger proteins, defines an evolutionarily conserved family that includes several developmentally regulated genes in Drosophila. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Silman,et al.  Twin concordance rates for rheumatoid arthritis: results from a nationwide study. , 1993, British journal of rheumatology.

[44]  S Hanash,et al.  Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. , 1990, Arthritis and rheumatism.

[45]  D H Sachs,et al.  Establishment and characterization of BALB/c lymphoma lines with B cell properties. , 1979, Journal of immunology.

[46]  Chris Cotsapas,et al.  Immune-mediated disease genetics: the shared basis of pathogenesis. , 2013, Trends in immunology.

[47]  T. Glant,et al.  Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis. , 2004, Methods in molecular medicine.

[48]  H. Joller-jemelka,et al.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. , 2002, The Journal of clinical investigation.